Home | Welcome to Contract Pharma   
Last Updated Thursday, October 30 2014
Print

Reckitt Benckiser to Spin Off its Pharma Businesses



Published July 29, 2014

Reckitt Benckiser plans to spin off its pharmaceuticals business during the next 12 months, according to Bloomberg reports.  The deal will be listed in the U.K., and the company may retain a stake after the spinoffs.  Most of the division's revenues reportedly come from Suboxone, used to treat opinoid addiction. The company is reportedly focusing on consumer healthcare, Bloomberg reports.
 



blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On